598 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
is not responsible for, and has no role in, the development of such products or programs.
Ligand owns or has rights to trademarks and copyrights
8-K
EX-99.1
zh53j6w4aykq4p5a8fch
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K/A
EX-99.1
b8urh
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
bgqs 4iycd9j
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
9tzm7gloa577r
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
cpbl0n 2q
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
l6ze2amupsz9oryfbe
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm